ArticleMolecular genetics and metabolism reports2025

Case report of neuronopathic mucopolysaccharidosis type II: Early intracerebroventricular enzyme replacement therapy and hematopoietic cell transplantation with developmental outcomes up to 5 years of age.

Azuma Ikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.